| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/25/2007 | CN1952133A Polynucleotide activating ELK1 activity and its encoded polypeptide and application |
| 04/25/2007 | CN1952132A Polynucleotide having influence on ELK1 activity and its encoded polypeptide and application |
| 04/25/2007 | CN1952127A Application of BPY2IP1 gene in inhibiting CRE activation |
| 04/25/2007 | CN1951950A Helicid modifier and its preparation method and uses |
| 04/25/2007 | CN1951939A Novel pyrrole derivatives as pharmaceutical agents |
| 04/25/2007 | CN1951503A Application of cytoskeleton like gene JWA in inhibiting toxicity of excitatory amino acid for treating Parkinson's diseases |
| 04/25/2007 | CN1951502A Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 04/25/2007 | CN1951501A Pharmaceutical composition with Meclofenoxate hydrochloride capable of preventing hydrolysis |
| 04/25/2007 | CN1951482A Chinese medicinal preparation for treating apoplexy sequelae |
| 04/25/2007 | CN1951478A Depression resisting beer |
| 04/25/2007 | CN1951474A A Chinese medicinal injection and preparation method thereof |
| 04/25/2007 | CN1951473A Quality control method of a Chinese medicinal injection |
| 04/25/2007 | CN1951459A Medicament for matching with holographic fire burning therapy in acupoints and preparation method thereof |
| 04/25/2007 | CN1951431A Quality control method of a pharmaceutical composition |
| 04/25/2007 | CN1951429A Preparation process of corydalis rhizome extract and novel usage thereof |
| 04/25/2007 | CN1951421A Pharmaceutical composition for resisting apoplexy and sequelae thereof and preparation process and preparation thereof |
| 04/25/2007 | CN1951417A Quality control method of a pharmaceutical composition |
| 04/25/2007 | CN1951415A Medicament for treating insanity |
| 04/25/2007 | CN1951410A Protecting agent for brain cell or nerve cell, consisting of ginseng |
| 04/25/2007 | CN1951395A Extraction and purification method of active constituents from stem of lonicera japonica thunb., its usage for anti-inflammatory and analgesic drug |
| 04/25/2007 | CN1951392A Compound medicament composed of gastrodine and ligustrazine |
| 04/25/2007 | CN1951390A Pharmaceutical compositions comprising colloidal silicon dioxide |
| 04/25/2007 | CN1951377A A colorless transparent healthcare drop used in cigarette |
| 04/25/2007 | CN1951375A Nicotine transdermal formulation and its production method |
| 04/25/2007 | CN1951373A Method for preparing nimodipine dispersible tablet with high dissolution |
| 04/25/2007 | CN1951372A Solid oral dosage forms comprising valsartan and HCTZ |
| 04/25/2007 | CN1951360A Complex salt crystal used for body surface physical therapy and preparation method thereof |
| 04/25/2007 | CN1951359A Multi-element compound physical therapeutic salt and preparation method thereof |
| 04/25/2007 | CN1312277C Marrow stroma cell directional differentiation induction method |
| 04/25/2007 | CN1312271C Method of whole manual culture for chinese caterpillar fungus |
| 04/25/2007 | CN1312181C Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 04/25/2007 | CN1312176C Buthotoxin polypeptide and preparation method thereof |
| 04/25/2007 | CN1312154C Purine derivatives as kinase inhibitors |
| 04/25/2007 | CN1312152C New purine derivatives |
| 04/25/2007 | CN1312151C (imidazol-1-yl-methyl)-pyridazine as NMDA receptor blocker |
| 04/25/2007 | CN1312148C Isochroman compounds for treatment of CNS disorders |
| 04/25/2007 | CN1312147C Substituted benzopyrans compounds as selective estrogen receptor-beta agonists |
| 04/25/2007 | CN1312139C Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 04/25/2007 | CN1312137C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 04/25/2007 | CN1312136C Triazole derivatives as tachykinin receptor antagonists |
| 04/25/2007 | CN1312132C 1-benzyl tetrahydro isoquinoline compound, its preparing process and use thereof |
| 04/25/2007 | CN1312129C Polymorphs of donepezil hydrochloride and process for production |
| 04/25/2007 | CN1312128C Method for preparing 13 5-triaminobenzene and hydrolyzing it into high-purity phloroglucinal |
| 04/25/2007 | CN1312120C Adamantane derivatives |
| 04/25/2007 | CN1311867C Nerve growth factor (NGF) preparation administered via nasal cavity |
| 04/25/2007 | CN1311841C Blood circulation promoting and pain alleviating soft capsule and its preparation |
| 04/25/2007 | CN1311821C Nerve fiber regeneration accelerator |
| 04/25/2007 | CN1311819C Crystalline composition containing escitalopram |
| 04/25/2007 | CN1311809C Process for preparing granular powder for treating neurosism and quality control method |
| 04/24/2007 | US7208629 5′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2007 | US7208602 N-sulfonyl- azetidines, pyrrolidines, piperidines and hexamethylenimines; treatment and prevention of Alzheimer's Disease and other diseases relating to the deposition of amyloid protein. |
| 04/24/2007 | US7208598 Trans-N2-(4-aminocyclohexyl)-N6-[2-[[[4-choro-3-trifluoromethyl)-phenyl]-methyl]-amino]-ethyl]-9-cyclopentyl-9H-purin-2,6-diamine trihydrochloride; cycline-dependent kinase proteins (cdk) inhibitor; animitotic, antitumor agents |
| 04/24/2007 | US7208596 Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof |
| 04/24/2007 | US7208584 Fibroblast growth factor-13 |
| 04/24/2007 | US7208527 Potassium channel modulators |
| 04/24/2007 | US7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 04/24/2007 | US7208499 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 04/24/2007 | US7208498 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/24/2007 | US7208495 Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof |
| 04/24/2007 | US7208489 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 04/24/2007 | US7208488 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |
| 04/24/2007 | US7208466 Treating pain or inflammation; inhibiting C-fibre neuron activity; hemagglutinins conjugated with protein |
| 04/24/2007 | US7208279 Method for identifying inhibitors of G protein coupled receptor signaling |
| 04/24/2007 | US7208270 Detecting demyelinating nervous system disorder by measurement of stem cell factor (SCF)-apoptosis-response gene protein(SARG-1-) protein; antiproliferative agents; microtubule associated protein 1(map1a); cancer screening |
| 04/24/2007 | US7208150 Non-toxic fraction isolated from the venom of Vipera xanthina, for therapy of pain |
| 04/24/2007 | US7208149 IL-16 antagonist peptides and DNA encoding the peptides |
| 04/24/2007 | CA2410852C 1-amino-alkylcyclohexanes as 5-ht3 and neuronal nicotinic receptor antagonists |
| 04/24/2007 | CA2403902C Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 04/24/2007 | CA2332931C The treatment of renal colic with gaba analogs |
| 04/24/2007 | CA2289574C 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
| 04/24/2007 | CA2289472C Excitatory amino acid receptor modulators |
| 04/24/2007 | CA2281545C N-heterocyclic derivatives as nos inhibitors |
| 04/24/2007 | CA2234610C New amino acid derivatives, processes for preparing them and pharmaceutical compositions containing these compounds |
| 04/24/2007 | CA2182771C 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/24/2007 | CA2167171C A method of protecting against neuron loss |
| 04/24/2007 | CA2154485C Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders |
| 04/24/2007 | CA2112703C Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse |
| 04/19/2007 | WO2007044779A1 Kinase inhibitors |
| 04/19/2007 | WO2007044215A1 Hexahydro cyclooctyl pyrazole cannabinoid modulators |
| 04/19/2007 | WO2007043939A1 Novel crystalline form of 3,5-dibromo-n- [(2s)-2-(-4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl] -n-methylbenzamide, modification a |
| 04/19/2007 | WO2007043938A1 NOVEL CRYSTALLINE FORM OF 3,5-DIBROMO-N- [ (2S) -2- (-4- FLUOROPHENYL) -4- (3-MORPHOLIN-4-YLAZTIDIN-l-YL) BUTYL] -N METHYLBENZAMIDE, MODIFICATION B |
| 04/19/2007 | WO2007043796A1 Composition comprising the fraction of salviae miltiorrhizae radix for treating or preventing cognitive dysfunction and use thereof |
| 04/19/2007 | WO2007043589A1 Animal model of schizophrenia |
| 04/19/2007 | WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043365A1 Therapeutic agent for neurogenic pain |
| 04/19/2007 | WO2007043363A1 Composition for use in prevention of hypoglycemic condition |
| 04/19/2007 | WO2007042668A1 Derivatives of 1-amino-isoquinoline, preparation method thereof and use of same in therapeutics in the treatment of a dysfunction associated with mch receptor 1 |
| 04/19/2007 | WO2007042571A1 Novel pyrimidine-2,4-diamine derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 04/19/2007 | WO2007042546A1 Imidazole derivatives for the treatment of anxiety and related diseases |
| 04/19/2007 | WO2007042545A1 Imidazole derivatives and their use for modulating the gaba-a receptor complex |
| 04/19/2007 | WO2007042544A2 Imidazole derivatives and their use for modulating the gabaa receptor complex |
| 04/19/2007 | WO2007042421A1 Imidazo benzodiazepine derivatives |
| 04/19/2007 | WO2007042420A1 Isoxazole derivatives |
| 04/19/2007 | WO2007042295A1 3, 5-disubstituted phenyl-piperidines as mdulators of dopamine? neurotransmission |
| 04/19/2007 | WO2007042250A1 Prolinamide derivatives as sodium channel modulators |
| 04/19/2007 | WO2007042240A1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels |
| 04/19/2007 | WO2007042239A1 Prolinamide derivatives as sodium channel modulators |
| 04/19/2007 | WO2007042035A2 Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders |
| 04/19/2007 | WO2007041969A1 Glycyrrhetinic acid-30-amide derivatives and the uses thereof |